Sign in

CIK 0001660334

  • Non-accelerated filer
  • Smaller reporting company

Verrica Pharmaceuticals Inc.

Sign in to watch
Ticker
VRCA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463137900
Phone
+1 484-453-3300
Business address
44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
  1. 4 Open-market buy Director bought 4,126,142 shares at $4.24 ($17,505,157)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale CHIEF LEGAL OFFICER sold 4,315 shares at $0.65 ($2,805)
  12. 4/A Grant or award Chief Medical Officer acquired 50,000 shares (grant or award)
  13. 4/A Grant or award CHIEF FINANCIAL OFFICER acquired 125,000 shares (grant or award)
  14. 4/A Grant or award CHIEF LEGAL OFFICER acquired 150,000 shares (grant or award)
  15. 4/A Grant or award PRESIDENT AND CEO acquired 150,000 shares (grant or award)
  16. 4/A Grant or award CHIEF COMMERCIAL OFFICER acquired 125,000 shares (grant or award)
  17. 4 Derivatives Options or other derivatives
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market buy CEO and President bought 280,898 shares
  20. 4 Open-market buy Director bought 1,123,595 shares

Page 2 of 13 · 253 filings